Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Lancet (London, England)|July 11, 2003
Targeting epidermal growth factor receptor--are we missing the mark?Janet E Dancey, Boris FreidlinCancer Cell|May 18, 2004
Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrowJanet E DanceyExpert Review of Anticancer Therapy|July 11, 2009
Kinase Inhibitor 4 Minisymposium summaryJanet E DanceyExpert Opinion on Investigational Drugs|April 19, 2005
Inhibitors of the mammalian target of rapamycinJanet E DanceyCancer Biology & Therapy|September 14, 2006
Therapeutic targets: MTOR and related pathwaysJanet E DanceyClinical Advances in Hematology & Oncology : H&O|November 1, 2005
mTOR inhibitors in hematologic malignanciesJanet E DanceyDrugs|May 25, 2007
Epidermal growth factor receptor inhibitors in non-small cell lung cancerJanet E DanceyHematology/Oncology Clinics of North America|January 7, 2003
Clinical development of mammalian target of rapamycin inhibitorsJanet E DanceyCancer Biology & Therapy|December 23, 2003
Recent advances of molecular targeted agents: opportunities for imagingJanet E DanceyFuture Oncology (London, England)|July 8, 2011
Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignanciesJanet E Dancey, Jose MonzonPageof 14